Active Filter(s):
Details:
Kures' flagship product, KUR-101, is a derivative of mitragynine, the major active alkaloid of the kratom plant. KUR-101 will join ATAI's pipeline of ground-breaking mental health interventions such as arketamine and psilocybin.
Lead Product(s): KUR-101
Therapeutic Area: Psychiatry/Psychology Product Name: KUR-101
Highest Development Status: Undisclosed Product Type: Small molecule
Partner/Sponsor/Collaborator: ATAI Life Sciences
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Acquisition July 09, 2020